ProfileGDS4718 / 237535_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 33% 38% 35% 45% 34% 33% 38% 37% 37% 38% 40% 36% 36% 37% 33% 35% 39% 32% 36% 37% 35% 32% 34% 37% 33% 38% 34% 32% 32% 35% 37% 37% 27% 36% 31% 38% 32% 38% 41% 40% 36% 35% 31% 32% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6824533
GSM549102patient 115, normal, homogenized [OPG study]4.9087938
GSM549104patient 119, normal, homogenized [OPG study]4.7567835
GSM549108patient 138, normal, homogenized [OPG study]5.279745
GSM549119patient 077, normal, homogenized [OPG study]4.7383434
GSM549133patient 032, cancer, homogenized [OPG study]4.6170133
GSM549139patient 042, cancer, homogenized [OPG study]4.8682438
GSM549099patient 107, normal, homogenized [OPG study]4.8566637
GSM549109patient 139, normal, homogenized [OPG study]4.8573737
GSM549110patient 046, normal, homogenized [OPG study]4.9270238
GSM549114patient 063, normal, homogenized [OPG study]4.9249740
GSM549122patient 082, normal, homogenized [OPG study]4.8226736
GSM549134patient 033, cancer, homogenized [OPG study]4.7842236
GSM549136patient 036, cancer, homogenized [OPG study]4.7944237
GSM549140patient 044, cancer, homogenized [OPG study]4.6473833
GSM549111patient 047, normal, homogenized [OPG study]4.7379935
GSM549113patient 057, normal, homogenized [OPG study]4.8629339
GSM549132patient 031, cancer, homogenized [OPG study]4.6040832
GSM549137patient 038, cancer, homogenized [OPG study]4.8020736
GSM549142patient 047, cancer, homogenized [OPG study]4.95637
GSM549100patient 110, normal, homogenized [OPG study]4.7995635
GSM549107patient 135, normal, homogenized [OPG study]4.5803832
GSM549115patient 068, normal, homogenized [OPG study]4.6616334
GSM549116patient 072, normal, homogenized [OPG study]4.8266237
GSM549120patient 078, normal, homogenized [OPG study]4.6593533
GSM549131patient 030, cancer, homogenized [OPG study]4.8492838
GSM549118patient 074, normal, homogenized [OPG study]4.7123534
GSM549129patient 027, cancer, homogenized [OPG study]4.6414732
GSM549123patient 088, normal, homogenized [OPG study]4.6020332
GSM549124patient 006, cancer, homogenized [OPG study]4.7923435
GSM549126patient 015, cancer, homogenized [OPG study]4.8529237
GSM549128patient 025, cancer, homogenized [OPG study]4.8146537
GSM549103patient 117, normal, homogenized [OPG study]4.484427
GSM549117patient 073, normal, homogenized [OPG study]4.7815736
GSM549138patient 041, cancer, homogenized [OPG study]4.5625731
GSM549141patient 045, cancer, homogenized [OPG study]4.8184638
GSM549130patient 028, cancer, homogenized [OPG study]4.6532632
GSM549101patient 111, normal, homogenized [OPG study]4.9184938
GSM549105patient 128, normal, homogenized [OPG study]5.0832641
GSM549106patient 134, normal, homogenized [OPG study]4.9261840
GSM549112patient 048, normal, homogenized [OPG study]4.7830236
GSM549125patient 011, cancer, homogenized [OPG study]4.7694635
GSM549127patient 024, cancer, homogenized [OPG study]4.568331
GSM549135patient 035, cancer, homogenized [OPG study]4.5864132